Published in Antimicrob Agents Chemother on February 18, 2014
Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa. Infect Chemother (2015) 0.86
Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure. Crit Care (2015) 0.85
Similar frequencies of Pseudomonas aeruginosa isolates producing KPC and VIM carbapenemases in diverse genetic clones at tertiary-care hospitals in Medellín, Colombia. J Clin Microbiol (2014) 0.79
Iminoguanidines as Allosteric Inhibitors of the Iron-Regulated Heme Oxygenase (HemO) of Pseudomonas aeruginosa. J Med Chem (2016) 0.79
Triethysilyl Enol Ethers in the Synthesis of Carbapenem Precursors. Tetrahedron Lett (2015) 0.77
When it comes to stewardship, it's time to get with the programmers. Can J Infect Dis Med Microbiol (2015) 0.76
Dexamethasone abrogates the antimicrobial and antibiofilm activities of different drugs against clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa. J Adv Res (2016) 0.75
Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem. BMC Infect Dis (2016) 0.75
Clinical features and risk factors for development of breakthrough Gram-negative bacteremia during carbapenem therapy. Antimicrob Agents Chemother (2016) 0.75
Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study. BMC Infect Dis (2014) 0.75
Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa. Open Microbiol J (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature (2000) 32.30
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev (2001) 15.81
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol (2008) 14.36
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80
The new beta-lactamases. N Engl J Med (2005) 5.12
Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol (2011) 3.49
Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother (1999) 3.16
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother (2006) 3.09
Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med (1999) 3.08
Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the Steris System 1 processor. Infect Control Hosp Epidemiol (2001) 2.84
Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med (2002) 2.64
First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States. Antimicrob Agents Chemother (2005) 2.29
Outbreak of multidrug-resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design. Infect Control Hosp Epidemiol (2009) 2.21
International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control (2011) 2.13
Why don't they listen? Adherence to recommendations of infectious disease consultations. Clin Infect Dis (2004) 2.13
Comparative review of the carbapenems. Drugs (2007) 2.06
Clinically significant carbapenemases: an update. Curr Opin Infect Dis (2008) 2.01
Risk factors for hospital-acquired pneumonia caused by imipenem-resistant Pseudomonas aeruginosa in an intensive care unit. Anaesth Intensive Care (2010) 1.94
Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis (2004) 1.89
Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis (1997) 1.82
Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs (2005) 1.78
Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol (2004) 1.77
Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol (2006) 1.76
Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis (1994) 1.69
Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect (2006) 1.61
Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care (2010) 1.59
An outbreak of post-cataract surgery endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology (2009) 1.43
Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections. J Hosp Infect (2004) 1.33
Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes. Infect Control Hosp Epidemiol (2010) 1.30
Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis (2001) 1.28
Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis (2001) 1.22
Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa. Microb Drug Resist (2005) 1.18
The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital. J Infect Dis (1989) 1.17
Multi-resistant Pseudomonas aeruginosa outbreak associated with contaminated tap water in a neurosurgery intensive care unit. J Hosp Infect (1998) 1.16
Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa. Diagn Microbiol Infect Dis (2007) 1.14
Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients. Antimicrob Agents Chemother (2007) 1.14
An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit. Infect Control Hosp Epidemiol (2002) 1.12
Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit. J Hosp Infect (2003) 1.11
Nosocomial infections caused by multiresistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol (1999) 1.10
Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients. Intensive Care Med (2001) 1.08
A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition. BMC Infect Dis (2011) 1.07
Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J Hosp Infect (2004) 1.06
Outbreak of Pseudomonas aeruginosa infection associated with contamination of a flexible bronchoscope. Infect Control Hosp Epidemiol (2009) 1.06
Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients. Transpl Infect Dis (2009) 1.05
Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer (2005) 1.04
Molecular epidemiology of outbreaks and containment of drug-resistant Pseudomonas aeruginosa in a Tokyo hospital. J Infect Chemother (2007) 1.02
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome. Microb Drug Resist (2011) 1.01
Pseudomonas aeruginosa bacteremia in children over ten consecutive years: analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes. J Korean Med Sci (2011) 1.00
Large outbreak in a surgical intensive care unit of colonization or infection with Pseudomonas aeruginosa that overexpressed an active efflux pump. Clin Infect Dis (2000) 0.99
Risk factors for recovery of imipenem- or ceftazidime-resistant pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil. Infect Control Hosp Epidemiol (2006) 0.99
A large outbreak of multiresistant Pseudomonas aeruginosa strains in north-eastern Germany. J Antimicrob Chemother (1999) 0.98
Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals. J Antimicrob Chemother (2006) 0.98
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. Epidemiol Infect (2011) 0.97
Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection. Int J Infect Dis (2010) 0.97
Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. Antimicrob Agents Chemother (2005) 0.95
Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type. Clin Microbiol Infect (2012) 0.95
Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe. J Hosp Infect (2011) 0.95
Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit. Indian J Pathol Microbiol (2009) 0.94
The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit. Burns (2005) 0.94
Pseudomonas aeruginosa in a neonatal intensive care unit: molecular epidemiology and infection control measures. BMC Infect Dis (2009) 0.93
Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit. J Hosp Infect (2010) 0.93
Pseudo-outbreak of multiresistant Pseudomonas aeruginosa in a hematology unit. Infect Control Hosp Epidemiol (1997) 0.93
Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa. Intensive Care Med (2007) 0.92
Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting. Infect Control Hosp Epidemiol (2011) 0.92
Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and new treatments. Br J Hosp Med (Lond) (2011) 0.92
[Outbreak of nosocomial urinary tract infections due to a multidrug resistant Pseudomonas aeruginosa]. Pathol Biol (Paris) (2003) 0.92
Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections. J Korean Med Sci (2008) 0.91
Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality. J Crit Care (2009) 0.91
Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol (2009) 0.91
Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients. J Hosp Infect (2005) 0.90
Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients. Intensive Care Med (2008) 0.90
Acquisition of extensive drug-resistant Pseudomonas aeruginosa among hospitalized patients: risk factors and resistance mechanisms to carbapenems. J Hosp Infect (2011) 0.90
An outbreak of carbapenem-resistant Pseudomonas aeruginosa in a urology ward. Clin Microbiol Infect (2003) 0.88
Use of pulsed-field gel electrophoresis as an epidemiologic tool during an outbreak of Pseudomonas aeruginosa lung infections in an intensive care unit. Intensive Care Med (1995) 0.87
Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates. Infect Control Hosp Epidemiol (2007) 0.85
Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms. Diagn Microbiol Infect Dis (2009) 0.85
Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital. Enferm Infecc Microbiol Clin (2009) 0.85
Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case-control study. Eur J Clin Microbiol Infect Dis (2009) 0.85
Surveillance of broad-spectrum antibiotic prescription in Singaporean hospitals: a 5-year longitudinal study. PLoS One (2011) 0.85
Risk factors of oropharyngeal carriage of Pseudomonas aeruginosa among patients from a Medical-Surgical Intensive Care Unit. Braz J Infect Dis (2009) 0.85
First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes. Int J Antimicrob Agents (2011) 0.84
Carbapenem-resistant Pseudomonas aeruginosa: factors influencing multidrug-resistant acquisition in non-critically ill patients. Eur J Clin Microbiol Infect Dis (2008) 0.84
Frequency of microbiologically correct antibiotic therapy increased by infectious disease consultations and microbiological results. J Clin Microbiol (2012) 0.84
Pseudo-outbreak of extremely drug-resistant pseudomonas aeruginosa urinary tract infections due to contamination of an automated urine analyzer. J Clin Microbiol (2012) 0.84
Identifying and controlling a multiresistant Pseudomonas aeruginosa outbreak in a Latin-American cancer centre and its associated risk factors. Braz J Infect Dis (2009) 0.82
Multidrug-resistant Pseudomonas aeruginosa cholangitis after endoscopic retrograde cholangiopancreatography: failure of routine endoscope cultures to prevent an outbreak. Infect Control Hosp Epidemiol (2004) 0.82
Contamination of a milk bank pasteuriser causing a Pseudomonas aeruginosa outbreak in a neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed (2003) 0.82
Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS. J Infect Dis (1995) 0.80
Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit. J Hosp Infect (2011) 0.80
Transmission of a multiresistant Pseudomonas aeruginosa strain at a German University Hospital. J Hosp Infect (2001) 0.80
Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures. Ann Pharmacother (2008) 0.79
The impact of total control of antibiotic prescribing by infectious disease specialist on antibiotic consumption and cost. J Chemother (2009) 0.79
Contaminated oral intubation equipment associated with an outbreak of carbapenem-resistant Pseudomonas in an intensive care unit. J Hosp Infect (2006) 0.79
Detection of SPM and IMP metallo-β-lactamases in clinical specimens of Pseudomonas aeruginosa from a Brazilian public tertiary hospital. Braz J Infect Dis (2012) 0.78
Intensification of antibiotic use within acute care hospitals in the Netherlands. J Antimicrob Chemother (2012) 0.78
Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unit. Acta Pharmacol Sin (2008) 0.78
Nosocomial acquisition of Pseudomonas aeruginosa resistant to both ciprofloxacin and imipenem: a risk factor and laboratory analysis. Eur J Clin Microbiol Infect Dis (2008) 0.77
[Experimental study and case control study of nosocomial infection caused by Pseudomonas aeruginosa]. Zhonghua Nei Ke Za Zhi (1990) 0.76
Controlling the clonal spread of Pseudomonas aeruginosa infection. Infect Control Hosp Epidemiol (2008) 0.76
The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis (2005) 9.80
Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med (2010) 8.50
Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet (2004) 5.27
Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med (2010) 4.61
Systematic review of studies on compliance with hand hygiene guidelines in hospital care. Infect Control Hosp Epidemiol (2010) 3.55
Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Ann Intern Med (2004) 2.84
Bacterial load in relation to vacuum-assisted closure wound therapy: a prospective randomized trial. Wound Repair Regen (2004) 2.05
Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol (2008) 1.57
Associations between Staphylococcus aureus Genotype, Infection, and In-Hospital Mortality: A Nested Case-Control Study. J Infect Dis (2005) 1.29
Optical fingerprinting in bacterial epidemiology: Raman spectroscopy as a real-time typing method. J Clin Microbiol (2008) 1.28
Rapid typing of extended-spectrum β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates by use of SpectraCell RA. J Clin Microbiol (2012) 1.07
Reduced costs for Staphylococcus aureus carriers treated prophylactically with mupirocin and chlorhexidine in cardiothoracic and orthopaedic surgery. PLoS One (2012) 1.06
Robust and censored modeling and prediction of progression in glaucomatous visual fields. Invest Ophthalmol Vis Sci (2013) 0.97
Survival of Staphylococcus aureus ST398 in the human nose after artificial inoculation. PLoS One (2012) 0.94
Detection of methicillin-resistant Staphylococcus aureus in a low-prevalence setting by polymerase chain reaction with a selective enrichment broth. Diagn Microbiol Infect Dis (2008) 0.94
Primary end-point error. Radiology (2010) 0.94
Determinants of carriage of resistant Escherichia coli in the Indonesian population inside and outside hospitals. J Antimicrob Chemother (2007) 0.93
Successful search-and-destroy policy for methicillin-resistant Staphylococcus aureus in The Netherlands. J Clin Microbiol (2005) 0.93
Optimizing structure-function relationship by maximizing correspondence between glaucomatous visual fields and mathematical retinal nerve fiber models. Invest Ophthalmol Vis Sci (2014) 0.91
Epidemiology of Staphylococcus aureus harboring the mecA or Panton-Valentine leukocidin genes in hospitals in Java and Bali, Indonesia. Am J Trop Med Hyg (2014) 0.91
Nasopharyngeal carriage of Klebsiella pneumoniae and other Gram-negative bacilli in pneumonia-prone age groups in Semarang, Indonesia. J Clin Microbiol (2013) 0.87
Identification of Acinetobacter isolates from species belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with monoclonal antibodies specific for O Antigens of their lipopolysaccharides. Clin Diagn Lab Immunol (2002) 0.87
Comparison of the accuracy of disk diffusion zone diameters obtained by manual zone measurements to that by automated zone measurements to determine antimicrobial susceptibility. J Microbiol Methods (2008) 0.85
An automated algorithm to preselect patients to be assessed individually in point prevalence surveys for hospital-acquired infections in surgery. Infect Control Hosp Epidemiol (2014) 0.84
Nose picking and nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol (2006) 0.84
Evaluation of an algorithm for electronic surveillance of hospital-acquired infections yielding serial weekly point prevalence scores. Infect Control Hosp Epidemiol (2014) 0.83
MRSA: We can overcome, but who will lead the battle? Infect Control Hosp Epidemiol (2005) 0.83
The ACCOMPLISH study. A cluster randomised trial on the cost-effectiveness of a multicomponent intervention to improve hand hygiene compliance and reduce healthcare associated infections. BMC Public Health (2011) 0.83
Fluoroquinolone-resistant Escherichia coli, Indonesia. Emerg Infect Dis (2005) 0.82
Histoplasma-associated inflammatory pseudotumour of the kidney mimicking renal carcinoma. Virchows Arch (2009) 0.81
Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections? Crit Care (2005) 0.80
Determinants of carriage of resistant Staphylococcus aureus among S. aureus carriers in the Indonesian population inside and outside hospitals. Trop Med Int Health (2010) 0.80
A comparative assessment of surgeons' tracking methods for surgical site infections. Surg Infect (Larchmt) (2013) 0.79
Long-term Mortality After Rapid Screening and Decolonization of Staphylococcus Aureus Carriers: Observational Follow-up Study of a Randomized, Placebo-controlled Trial. Ann Surg (2016) 0.78
Comparative genomics of epidemic versus sporadic Staphylococcus aureus strains does not reveal molecular markers for epidemicity. Infect Genet Evol (2009) 0.78
Universal screening for methicillin-resistant Staphylococcus aureus by hospitals. JAMA (2008) 0.77
Reply to Saliou et al. Endoscopy (2015) 0.75
Retracted Aortic homograft endocarditis caused by Campylobacter jejuni. J Clin Microbiol (2011) 0.75
Control of nosocomial methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis (2006) 0.75
Fatal Mycobacterium bovis bacille Calmette-Guérin infection caused by contamination of chemotherapeutic agents and not by endogenous reactivation: correction of a previous conclusion. Clin Infect Dis (2003) 0.75
[Prevention of infections with highly resistant microorganisms: maximizing transparency by using outcome indicators]. Ned Tijdschr Geneeskd (2015) 0.75
Improving hand hygiene compliance in hospitals by design. Infect Control Hosp Epidemiol (2012) 0.75
[Does ultraclean air in the operating room provide greater safety?]. Ned Tijdschr Geneeskd (2010) 0.75
[Infection prevention in Dutch hospitals; results say more than process indicators]. Ned Tijdschr Geneeskd (2014) 0.75